Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate

SIMPLE SUMMARY: Eribulin mesylate, an anti-mitotic drug used for the treatment of metastatic breast cancer (BC), exhibits significant effects on cancer cell migration, invasion, and metastatic seeding in experimental models. Interestingly, eribulin treatment has been shown to target the cancer stem...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadaki, Maria A., Mala, Anastasia, Merodoulaki, Aikaterini C., Vassilakopoulou, Maria, Mavroudis, Dimitrios, Agelaki, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405936/
https://www.ncbi.nlm.nih.gov/pubmed/36010896
http://dx.doi.org/10.3390/cancers14163903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405936/
https://www.ncbi.nlm.nih.gov/pubmed/36010896
http://dx.doi.org/10.3390/cancers14163903

Ejemplares similares